Cargando…

Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) in adulthood is not fully treated by psychopharmacological treatment alone. The main aim of the current study was to evaluate a newly developed cognitive behaviour therapy (CBT) based group programme, the Reasoning and Rehabilitation for AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Emilsson, Brynjar, Gudjonsson, Gisli, Sigurdsson, Jon F, Baldursson, Gisli, Einarsson, Emil, Olafsdottir, Halldora, Young, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155481/
https://www.ncbi.nlm.nih.gov/pubmed/21787431
http://dx.doi.org/10.1186/1471-244X-11-116
_version_ 1782210122051747840
author Emilsson, Brynjar
Gudjonsson, Gisli
Sigurdsson, Jon F
Baldursson, Gisli
Einarsson, Emil
Olafsdottir, Halldora
Young, Susan
author_facet Emilsson, Brynjar
Gudjonsson, Gisli
Sigurdsson, Jon F
Baldursson, Gisli
Einarsson, Emil
Olafsdottir, Halldora
Young, Susan
author_sort Emilsson, Brynjar
collection PubMed
description BACKGROUND: Attention deficit hyperactivity disorder (ADHD) in adulthood is not fully treated by psychopharmacological treatment alone. The main aim of the current study was to evaluate a newly developed cognitive behaviour therapy (CBT) based group programme, the Reasoning and Rehabilitation for ADHD Youths and Adults (R&R2ADHD), using a randomized controlled trial. METHODS: 54 adults with ADHD already receiving psychopharmacological treatment were randomly allocated to an experimental (CBT/MED) treatment condition (n = 27) and a 'treatment as usual' (TAU/MED) control condition (n = 27) that did not receive the CBT intervention. The outcome measures were obtained before treatment (baseline), after treatment and at three month follow-up and included ADHD symptoms and impairments rated by independent assessors, self-reported current ADHD symptoms, and comorbid problems. RESULTS: The findings suggested medium to large treatment effects for ADHD symptoms, which increased further at three month follow-up. Additionally, comorbid problems also improved at follow-up with large effect sizes. CONCLUSIONS: The findings give support for the effectiveness of R&R2ADHD in reducing ADHD symptoms and comorbid problems, an improving functions associated with impairment. The implications are that the benefits of R&R2ADHD are multifaceted and that combined psychopharmacological and CBT based treatments may add to and improve pharmacological interventions. TRIAL REGISTRATION: ACTRN12611000533998 (http://www.ANZCTR.org.au/ACTRN12611000533998.aspx)
format Online
Article
Text
id pubmed-3155481
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31554812011-08-13 Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial Emilsson, Brynjar Gudjonsson, Gisli Sigurdsson, Jon F Baldursson, Gisli Einarsson, Emil Olafsdottir, Halldora Young, Susan BMC Psychiatry Research Article BACKGROUND: Attention deficit hyperactivity disorder (ADHD) in adulthood is not fully treated by psychopharmacological treatment alone. The main aim of the current study was to evaluate a newly developed cognitive behaviour therapy (CBT) based group programme, the Reasoning and Rehabilitation for ADHD Youths and Adults (R&R2ADHD), using a randomized controlled trial. METHODS: 54 adults with ADHD already receiving psychopharmacological treatment were randomly allocated to an experimental (CBT/MED) treatment condition (n = 27) and a 'treatment as usual' (TAU/MED) control condition (n = 27) that did not receive the CBT intervention. The outcome measures were obtained before treatment (baseline), after treatment and at three month follow-up and included ADHD symptoms and impairments rated by independent assessors, self-reported current ADHD symptoms, and comorbid problems. RESULTS: The findings suggested medium to large treatment effects for ADHD symptoms, which increased further at three month follow-up. Additionally, comorbid problems also improved at follow-up with large effect sizes. CONCLUSIONS: The findings give support for the effectiveness of R&R2ADHD in reducing ADHD symptoms and comorbid problems, an improving functions associated with impairment. The implications are that the benefits of R&R2ADHD are multifaceted and that combined psychopharmacological and CBT based treatments may add to and improve pharmacological interventions. TRIAL REGISTRATION: ACTRN12611000533998 (http://www.ANZCTR.org.au/ACTRN12611000533998.aspx) BioMed Central 2011-07-25 /pmc/articles/PMC3155481/ /pubmed/21787431 http://dx.doi.org/10.1186/1471-244X-11-116 Text en Copyright ©2011 Emilsson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Emilsson, Brynjar
Gudjonsson, Gisli
Sigurdsson, Jon F
Baldursson, Gisli
Einarsson, Emil
Olafsdottir, Halldora
Young, Susan
Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title_full Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title_fullStr Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title_full_unstemmed Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title_short Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial
title_sort cognitive behaviour therapy in medication-treated adults with adhd and persistent symptoms: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155481/
https://www.ncbi.nlm.nih.gov/pubmed/21787431
http://dx.doi.org/10.1186/1471-244X-11-116
work_keys_str_mv AT emilssonbrynjar cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT gudjonssongisli cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT sigurdssonjonf cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT baldurssongisli cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT einarssonemil cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT olafsdottirhalldora cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial
AT youngsusan cognitivebehaviourtherapyinmedicationtreatedadultswithadhdandpersistentsymptomsarandomizedcontrolledtrial